Response to Intensive Therapy Steps and to Glipizide Dose in Combination With Insulin in Type 2 Diabetes: VA feasibility study on glycemic control and complications (VA CSDM)

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Diabetes Care

• Publication date

  1998-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.2337/diacare.21.4.574PMID 9571345
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of sulphonylurea on glucose-stimulated insulin secretion in healthy and non-insulin dependent diabetic subjects: a dose-response study

  2004cited by this paper
• The Diabetes Control and Complications Trial

  1998cited by this paper
• Cardiovascular events and correlates in the Veterans Affairs Diabetes Feasibility Trial. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes.

  1997cited by this paper
• Pre‐meal Insulin Analogue Insulin Lispro vs Humulin® R Insulin Treatment in Young Subjects with Type 1 Diabetes

  1996cited by this paper
• The Pharmacological Treatment of Hyperglycemia in NIDDM

  1996cited by this paper
• Evaluations of Retinopathy in the VA Cooperative Study on Glycemic Control and Complications in Type II Diabetes (VA CSDM): A feasibility study

  1996cited by this paper
• American Diabetes Association Postgraduate Course, 1996: Treatment and Prevention of Diabetes

  1996cited by this paper
• United Kingdom prospective diabetes study (UKPDS) 13: relative efficacy of randomly allocated diet, sulphonylurea, insulin, or metformin in patients with newly diagnosed non-insulin dependent diabetes followed for three years

  1995cited by this paper
• Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study.

  1995cited by this paper
• Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes (VA CSDM): Results of the feasibility trial

  1995cited by this paper
• The Benefit of Increasing Sulfonylurea Dose

  1993cited by this paper
• Comparison of Morning or Bedtime Insulin With and Without Glyburide in Secondary Sulfonylurea Failure

  1993cited by this paper
• The Benefit of Increasing Sulfonylurea Dose

  1993cited by this paper
• The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

  1993cited by this paper
• Combination Therapy in NIDDM

  1993cited by this paper
• Comparison of insulin regimens in patients with non-insulin-dependent diabetes mellitus.

  1992cited by this paper
• Combination therapy in NIDDM.

  1992cited by this paper
• Glycemic Control and Complications in Type II Diabetes: Design of a feasibility trial

  1992cited by this paper
• Insulin Use in NIDDM

  1990cited by this paper

• Efficacy and safety of intensive versus conventional glucose targets in people with type 2 diabetes: a systematic review and meta-analysis

  2023cites this paper
• Antidiabetic drugs and blood pressure changes.

  2020cites this paper
• Hypoglycemia

  2020cites this paper
• Effects of glucose-lowering on outcome incidence in diabetes mellitus and the modulating role of blood pressure and other clinical variables: overview, meta-analysis of randomized trials.

  2019cites this paper
• Hypoglycemia

  2019cites this paper
• Pharmacokinetics Analysis of Controlled Insulin Delivery from Biodegradable Polymer Matrix

  2018cites this paper
• Prevention and Management of Severe Hypoglycemia and Hypoglycemia Unawareness: Incorporating Sensor Technology

  2018cites this paper
• Glucose targets for preventing diabetic kidney disease and its progression.

  2017cites this paper
• Insulin monotherapy compared with the addition of oral glucose-lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control.

  2016cites this paper
• Withdrawal of sulfonylureas from patients with type 2 diabetes receiving long-term sulfonylurea and insulin combination therapy results in deterioration of glycemic control: a randomized controlled trial

  2015cites this paper
• Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease.

  2015cites this paper
• WITHDRAWN: Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus.

  2015cites this paper
• Effect of sulfonylurea dose escalation on hemoglobin A1c in Veterans Affairs patients with type 2 diabetes

  2013influential citation
• The Role of Sulphonylureas in the Management of Type 2 Diabetes Mellitus

  2012cites this paper
• Pathogenesis of Type 2 Diabetes

  2012cites this paper
• Combination therapy with GLP-1 receptor agonists and basal insulin: a systematic review of the literature

  2012cites this paper
• Use of Twice-Daily Exenatide in Basal Insulin–Treated Patients With Type 2 Diabetes

  2011cites this paper
• Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus

  2011cites this paper
• Intensive glycaemic control for patients with type 2 diabetes: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials

  2011cites this paper
• Sulfonylureas: do we need to introspect safety again?

  2011cites this paper
• Medical Antihyperglycaemic Treatment of Type 2 Diabetes Mellitus*

  2009cites this paper
• Role of surgery in management of type 2 diabetes mellitus.

  2009cites this paper
• Medikamentöse antihyperglykämische Therapie des Diabetes mellitus Typ 2

  2009cites this paper
• Type 2 Diabetes and Concomitant Illness

  2008cites this paper
• Prevention of Hypoglycemia While Achieving Good Glycemic Control in Type 1 Diabetes

  2008cites this paper
• Impact of therapeutic advances on hypoglycaemia in type 2 diabetes

  2008cites this paper
• Insulin therapy for type 2 diabetes: premixed or basal-prandial?

  2007cites this paper
• Applicability of the Evidence Regarding Intensive Glycemic Control and Self-Monitored Blood Glucose to Medicare Patients with Type 2 Diabetes

  2007influential citation
• Effectiveness of Intensive Insulin Therapy by Multiple Daily Injections and Continuous Subcutaneous Infusion: A Comparison Study in Type 2 Diabetes with Conventional Insulin Regimen Failure

  2007cites this paper
• Facteurs déterminants du contrôle glycémique des patients diabétiques de type 2 suivis en première ligne

  2006cites this paper
• An Integrated Graphic Scheme for the Display of Insulin Prescription and Blood Glucose Information

  2006cites this paper
• Rationale, design, and methods for glycemic control in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial.

  2006cites this paper
• [Predictive factors of glycemic control in patients with type 2 diabetes mellitus in primary health care].

  2006cites this paper
• Guías ALAD 2006 de diagnóstico control y tratamiento de la Diabetes Mellitus Tipo 2.

  2006cites this paper
• Health-related quality of life in the VA Feasibility Study on glycemic control and complications in type 2 diabetes mellitus.

  2005cites this paper
• An algorithm for the treatment of type 2 diabetes in Latin America

  2005cites this paper
• Early insulin: an important therapeutic strategy.

  2005cites this paper
• Effektivität des PROSIT-Interventionsprogramms in Bezug auf die Blutglukoseeinstellung bei Typ 2-diabetischen Patienten

  2005cites this paper
• Hospital Management of Hyperglycemia

  2004cites this paper
• Insulin therapy and hypoglycaemia: the size of the problem

  2004cites this paper
• Initiating insulin in type 2 diabetes mellitus: the earlier the better.

  2004cites this paper
• Intense Management of Diabetes Mellitus: Role of Glucose Control and Antiplatelet Agents

  2004cites this paper
• Postprandial hyperglycaemia in type 2 diabetes: pathophysiological aspects, teleological notions and flags for clinical practice

  2004cites this paper
• Insulinothérapie dans le diabète de type 2

  2004cites this paper
• Effect of Intensive Glycemic Control on Macrovascular Events in Patients with Diabetes Mellitus

  2003cites this paper
• Differential Adoption of Pharmacotherapy Recommendations for Type 2 Diabetes by Generalists and Specialists

  2003cites this paper
• Endocrine Replacement Therapy in Clinical Practice

  2003influential citation
• Using new insulin strategies in the outpatient treatment of diabetes: clinical applications.

  2003cites this paper
• The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients.

  2003cites this paper
• Treatment of Type 2 Diabetes

  2003cites this paper
• Should postprandial glucose be measured and treated to a particular target? Yes.

  2003cites this paper
• Outpatient insulin therapy in type 1 and type 2 diabetes mellitus: scientific review.

  2003cites this paper
• Comparison of metformin versus sulphonylurea in combination with daily NPH insulin in patients with type 2 diabetes inadequately controlled on hypoglycaemic agents; median follow‐up“29 months

  2002cites this paper
• The contribution of metformin to glycaemic control in patients with Type 2 diabetes mellitus receiving combination therapy with insulin.

  2002cites this paper
• Is Postprandial Glucose Control Important? Is It Practical In Primary Care Settings?

  2002cites this paper
• Treating hyperglycemia in type 2 diabetes: new goals and strategies.

  2002cites this paper
• Cardiovascular Risk Management in Type 2 Diabetes: From Clinical Trials to Clinical Practice

  2001cites this paper
• la terapia combinada en la diabetes mellitus tipo 2. Criterios y pautas.

  2001cites this paper
• [The COMBO project. Criteria and guidelines for combined therapy of type 2 diabetes. Consensus document (and II)].

  2001cites this paper
• Hypoglycemia: An Excuse for Poor Glycemic Control?

  2001cites this paper
• [Type 2 diabetes: what therapeutic strategy?].

  2001cites this paper
• [Present and future of insulin therapy in type 2 diabetic patients].

  2001cites this paper
• Proyecto COMBO: Criterios y pautas de terapia combinada en la diabetes tipo 2. Documento de consenso (y II)

  2001cites this paper
• Insulin therapy in type 2 diabetes.

  2001cites this paper
• Criterios y pautas de terapia combinada en la diabetes tipo 2

  2001cites this paper
• Repaglinide in Type 2 Diabetes: A 24‐Week, Fixed‐Dose Efficacy and Safety Study

  2000cites this paper
• Eficacia del tratamiento con metformina en pacientes con diabetes mellitus tipo 2 pobremente controlada con insulinoterapia

  2000cites this paper
• A m bu l a t o ry Care

  2000cites this paper
• [Effectiveness of treatment with metformin in patients with type 2 diabetes mellitus poorly controlled with insulin treatment].

  2000cites this paper
• What do the needles, syringes, lancets and reagent strips of diabetic patients become in the absence of a common attitude? About 1070 questionnaires in diabetic clinics.

  2000cites this paper
• Effect of intensive glycemic control on microalbuminuria in type 2 diabetes. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type 2 Diabetes Feasibility Trial Investigators.

  2000cites this paper
• Pharmacotherapy of Type 2 Diabetes Mellitus

  2000cites this paper
• Glycemic control and cardiovascular disease in Type 2 diabetes: a review

  1999cites this paper
• Intensive insulin therapy in patients with type 2 diabetes: implications of the Veterans affairs (VA CSDM) feasibility trial.

  1999cites this paper
• Benefits and Risks of Transfer from Oral Agents to Insulin in Type 2 Diabetes Mellitus

  1999cites this paper
• The use of insulin alone and in combination with oral agents in type 2 diabetes.

  1999cites this paper